Skip to main content
Mankind Pharma Limited (NSE:MANKIND)
India flag India · Delayed Price · Currency is INR
2,256.80
-7.60 (-0.34%)
Apr 29, 2026, 3:29 PM IST

Mankind Pharma Revenue

Mankind Pharma had revenue of 35.67B INR in the quarter ending December 31, 2025, with 10.44% growth. This brings the company's revenue in the last twelve months to 139.14B, up 19.53% year-over-year. In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B with 18.98% growth.

Revenue (ttm)
139.14B
Revenue Growth
+19.53%
P/S Ratio
6.70
Revenue / Employee
7.09M
Employees
19,620
Market Cap
931.67B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025122.07B19.47B18.98%
Mar 31, 2024102.60B15.11B17.27%
Mar 31, 202387.49B9.68B12.44%
Mar 31, 202277.82B15.67B25.22%
Mar 31, 202162.14B3.43B5.83%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zydus Lifesciences 260.89B
Cipla 279.67B
Aurobindo Pharma 331.82B
Glenmark Pharmaceuticals 165.10B
Alkem Laboratories 142.53B
Laurus Labs 67.22B
Divi's Laboratories 103.14B
Ipca Laboratories 95.06B
Revenue Rankings

Mankind Pharma News

More News